focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,783.50
Bid: 1,780.00
Ask: 1,780.50
Change: -29.00 (-1.60%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,775.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amazon and Nestle join public-private plan to save world's forests

Thu, 22nd Apr 2021 15:30

* LEAF coalition aims to raise an initial $1 bln

* Calls for countries to apply by July

* Payouts linked to emissions between 2022-2026

By Simon Jessop

LONDON, April 22 (Reuters) - The United States, Norway and
Britain joined forces with companies including Amazon
and Nestle on Thursday to launch a project aimed at
protecting the world's tropical forests.

Announcing the Lowering Emissions by Accelerating Forest
finance (LEAF) Coalition at the U.S.-convened Leaders Summit on
climate, the public-private project aims to raise at least $1
billion in initial financing, it said.

Governments and companies taking part will pay countries
with tropical and subtropical forests for emissions reductions,
a move it hopes will help reduce and eventually end
deforestation.

As the world looks to move quickly to a low-carbon economy
to prevent catastrophic climate change, protecting the forests
that help remove carbon from the atmosphere naturally is seen as
a crucial step, but one that has so far largely failed.

The pace of deforestation actually picked up in 2020, LEAF
said, with data from Global Forest Watch showing a 12 percent
increase from the prior year or more than 10 million hectares of
primary tropical forest, roughly the size of Switzerland.

"The LEAF coalition is a groundbreaking example of the scale
and type of collaboration that is needed to fight the climate
crisis and achieve net-zero emissions globally by 2050," said
U.S. Special Presidential Envoy for Climate John Kerry.

"Bringing together government and private-sector resources
is a necessary step in supporting the large-scale efforts that
must be mobilized to halt deforestation and begin to restore
tropical and subtropical forests."

Countries looking to take part in the programme will need to
have the reduction in deforestation-linked emissions verified by
a new, more rigorous standard assessed at the national level by
an independent third party, the coalition said in a statement.

With applications due by July 2021 and the aim of signing
contracts before the end of the year, payments would be based on
emissions reductions linked to reducing levels of deforestation
or degradation, or by restoring forests, between 2022 and 2026.

Companies looking to take part in the project will only be
allowed to join if they can show a commitment to "deep voluntary
cuts" in their own emissions, in line with science-based targets
and the Paris Agreement on climate.

"Climate change is the greatest threat to our planet, and
the LEAF coalition offers us an opportunity to bring together
governments and companies to fight it," said Jeff Bezos, Amazon
founder and CEO.

"In uniting behind a common cause, the countries and
companies of the coalition have a chance to end deforestation by
2030."

Among other companies to sign up to the project are Airbnb
, Boston Consulting Group, GlaxoSmithKline,
McKinsey, Salesforce, Bayer and Unilever
, although more are expected to join over time.

U.S. non-profit Emergent will oversee the administration of
the project.
(Reporting by Simon Jessop; Editing by Nick Macfie)

More News
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.